myDNA Pharmacogenomics Cardiovascular Medication Test

This DNA test helps you discover your response to certain cardiovascular medications, including beta blockers, statins, and anticoagulants. The test identifies common genetic variations in the genes encoding drug-metabolising enzymes (such as Cytochrome P450 enzymes) and transport proteins, which can affect the activity of these medications. For example, in intermediate or poor metabolisers, reduced metabolism may lead to increased plasma concentrations of a drug, raising the risk of side effects or toxicity from standard doses. Conversely, rapid or ultrarapid metabolisers may eliminate the drug too quickly, resulting in lower plasma concentrations and potentially reduced therapeutic effectiveness. Understanding these genetic variations can guide personalised dosing and medication selection, improving treatment outcomes.